OUD: chronic pain not influenced by switch to opioid antagonist or agonist

  • Latif ZE & al.
  • Am J Addict
  • 31 Jan 2019

  • curated by Kelli Whitlock Burton
  • Clinical Essentials
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Patients with chronic pain and opioid-use disorder (OUD) did not experience any increase in pain after switching from daily opioid use to either extended-release naltrexone (XR-NTX) or buprenorphine-naloxone (BP-NLX).
  • In a longer follow-up, patients who switched from maintenance therapy with daily BP-NLX to maintenance with XR-NTX also reported no increase in pain.

Why this matters

  • This is the first study to compare the effects of XR-NTX and BP-NLX on chronic mild to moderate pain in opioid-dependent patients and challenges the perception that XR-NTX and other opioid antagonists may aggravate pain in opioid-dependent patients with chronic pain.

Study design

  • 143 participants (age, 18-60 years) with chronic pain and opioid dependencies evaluated.
  • After opioid detoxification, patients were randomly allocated to either intramuscular XR-NTX (380 mg every fourth week) or sublingual BP-NLX (4-24 mg daily) for 12 weeks, followed by 36 weeks of follow-up, in which participants chose treatment with either drug.
  • Funding: Research Council of Norway.

Key results

  • Between weeks 4 and 12, no significant difference in mean present pain intensity, visual analogue scale, or sensory and affective pain scores was observed within treatment groups.
  • After week 12, participants who switched from BP-NLX to XR-NTX treatment reported no increase in pain intensity during longer-term treatment.

Limitations

  • Open-label study.

Coauthored with Antara Ghosh, PhD

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit